Home ›
NPI 1316311863
NPI deactivated
1316311863
1316311863 was paid $10.77M by Medicaid between Sep 2019 and Jan 2023, across 24 billing codes. Its largest line is 81406, — 27% of everything it billed.
33Billing provider info1316311863
33aNPI1316311863
33bProvider type—
28Total paid$10.77M
24GClaims22,294
24DCodes billed24
24AFirst – last monthSep 2019 – Jan 2023
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 11,323 | $6.51M | |
| 2020 | 8,754 | $4.19M | |
| 2022 | 1,821 | $58K | |
| 2023 | 396 | $15K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 81406 | 27% | 2,971 | 2,666 | $2.86M | |
| 81407 | 17% | 2,399 | 2,256 | $1.88M | |
| 81443 | 17% | 908 | 878 | $1.83M | |
| 81432 | 17% | 2,675 | 2,400 | $1.80M | |
| 81203 | 5.6% | 2,586 | 2,335 | $598K | |
| 81408 | 3.9% | 340 | 324 | $416K | |
| 81162 | 3.9% | 295 | 284 | $416K | |
| 81319 | 3.5% | 2,618 | 2,362 | $382K | |
| 81317 | 1.4% | 573 | 561 | $146K | |
| 81435 | 1.2% | 294 | 284 | $133K | |
| 81404 | <1% | 714 | 680 | $98K | |
| 81405 | <1% | 302 | 288 | $65K |
12 more codes
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 723 | $45K |
| 81403 | <1% | 713 | $36K | |
| 81439 | <1% | 23 | $13K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 414 | $13K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 727 | $12K |
| 81238 | <1% | 22 | $12K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 410 | $6K |
| 81286 | <1% | 22 | $5K | |
| 81184 | <1% | 22 | $2K | |
| 81201 | <1% | 282 | $780.00 | |
| 81479 | Unlisted molecular pathology procedure | <1% | 2,136 | $447.32 |
| 81292 | 0% | 125 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.